doctor prescribed semaglutide new orleans Medicus Weight Loss Clinic in Orleans, LA Some doctors are embracing compounded

PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways across 49 peptides to identify your unique responder profile

SURMOUNT-5 Trial Overview SURMOUNT-5 (NCT05822830) is a multicenter, randomized, open-label Phase 3b trial aimed at assessing the efficacy and safety of Zepbound (tirzepatide) compared to Wegovy (semaglutide) in adults with obesity or overweight, with at least one comorbidity (such as hypertension, dyslipidemia, obstructive sleep apnea (OSA), or cardiovascular disease), and no diabetes

Both reduce inflammation and support barrier function

Swords FM et al (2005) The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: Does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushings disease

IRB-2021-006-02)